Excited to share our systematic review and meta-analysis of standard- versus reduced-dose sotorasib in KRAS G12C-mutated NSCLC, now published in @JCOOP_ASCO
Reduced dosing did not appear to substantially compromise efficacy, supporting dose optimization efforts aligned with FDA Project Optimus.
Grateful to my coauthors for their contributions to this work.
@NagashreeSeeth1@DivyaReddyMD@KRASKickers
#KRAS #ProjectOptimus #LCSM
https://t.co/c0pEd8KjBN
It was a privilege to present our work on recurrence in KRAS-mutant LUAD and receive thoughtful feedback from faculty.
Our findings highlight an association between KRAS G12C, oxidative phosphorylation activity, and recurrence after resection. #TexasLung.
We're thrilled to announce the winners of the #TexasLung26 poster competition whose outstanding abstracts highlight important research shaping the future of lung cancer care. Join them at the poster session & welcome reception on April 9, 2026, in Austin, TX—this is where the future of lung cancer innovation comes to life! Congratulations to @JackieAredoMD, Zhaohui Arter, @yajur_arya, Wint Aung, @RobertoBoreaMD, @KCargillMDPhD, @DivyaReddyMD, @GraceHaMD, Pragya Jain, John Nawrocki, Max Schuessler, Xin Sun, Lauryn Tu, and Alessandra Vaccaro. https://t.co/4Z7OOs4SEy
We’re excited to announce the winners of the #NashvilleHeme26 Poster Competition! 🏅 Congratulations to Drs. @amishagupta2012, @DivyaReddyMD, Anthony Corsi, Matthew Gromowsky, @KellyMezaMD, Phyu Naing, Neha Puttagunta, @RahulShahK, Jessica Shostak, @rahul2u, Chidiebube Ugwu, and Graham Wehmeyer.
Join them at the Poster Session & Welcome Reception, Feb. 26 in Nashville, TN at the 2-Day CE conference. Register today! https://t.co/UKAji8cHIn
👏👏#CME.
A VERY applicable case presented by THE AMAZING @NagashreeSeeth1 of discovering Met amp.
A reminder to 👀 for MET and HER IHC on all our patients. We have approvals for these with TELISO-V and TDX-D
#NYL25@gotoPER@NorthwellHealth
Thrilled to present our work, “Prognostic Impact of TP53 Co-Mutations with EGFR vs KRAS in Advanced NSCLC: A cBioPortal Analysis,” at #WCLC2025 in Barcelona! Huge thanks to my amazing mentor! @NagashreeSeeth1@IASLC@Arthur_Aung@NorthwellHealth
My amazing fellow, @DivyaReddyMD is headed to Barcelona to present her poster #WCLC25@IASLC ‘Prognostic Impact of TP53 Co-Mutations with EGFR vs KRAS in Advanced Non-Small Cell Lung Cancer: A cBioPortal Analysis’. Pls come by on Mondayto check it out!!💙
So grateful to the @OncLive team for helping us host the first fellows forum at #ILCC2025
We planned it in several weeks and it was a great opportunity for fellows to learn from global faculty Drs. @TonyMok9 and @peters_solange
Northwell heme/onc fellows, @DivyaReddyMD, @mneuman96g were unable to attend #WCLC2024 but I am so proud of their work and dedication to lung cancer research.